Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,004 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GREAT/LGR8 is the only receptor for insulin-like 3 peptide.
Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI. Bogatcheva NV, et al. Among authors: feng s. Mol Endocrinol. 2003 Dec;17(12):2639-46. doi: 10.1210/me.2003-0096. Epub 2003 Aug 21. Mol Endocrinol. 2003. PMID: 12933905
Endocrine effects of relaxin overexpression in mice.
Feng S, Bogatcheva NV, Kamat AA, Truong A, Agoulnik AI. Feng S, et al. Endocrinology. 2006 Jan;147(1):407-14. doi: 10.1210/en.2005-0626. Epub 2005 Oct 13. Endocrinology. 2006. PMID: 16223865
The role of relaxin in endometrial cancer.
Kamat AA, Feng S, Agoulnik IU, Kheradmand F, Bogatcheva NV, Coffey D, Sood AK, Agoulnik AI. Kamat AA, et al. Among authors: feng s. Cancer Biol Ther. 2006 Jan;5(1):71-7. doi: 10.4161/cbt.5.1.2289. Epub 2006 Jan 31. Cancer Biol Ther. 2006. PMID: 16322684
T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane.
Bogatcheva NV, Ferlin A, Feng S, Truong A, Gianesello L, Foresta C, Agoulnik AI. Bogatcheva NV, et al. Among authors: feng s. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E138-44. doi: 10.1152/ajpendo.00228.2006. Epub 2006 Aug 22. Am J Physiol Endocrinol Metab. 2007. PMID: 16926383 Free article.
Relaxin promotes prostate cancer progression.
Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Feng S, et al. Clin Cancer Res. 2007 Mar 15;13(6):1695-702. doi: 10.1158/1078-0432.CCR-06-2492. Clin Cancer Res. 2007. PMID: 17363522
Relaxin/RXFP1 signaling in prostate cancer progression.
Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Feng S, et al. Ann N Y Acad Sci. 2009 Apr;1160:379-80. doi: 10.1111/j.1749-6632.2008.03793.x. Ann N Y Acad Sci. 2009. PMID: 19416223 Free PMC article.
9,004 results